相关实验视频

Updated: Jun 5, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K

PD-1封锁是否改变了对cHL的标准护理?

Thomas M Kuczmarski1, Ryan C Lynch1

  • 1University of Washington, Fred Hutchinson Cancer Center, Seattle, WA.

Hematology. American Society of Hematology. Education Program
|December 7, 2024
PubMed
概括

编程细胞死亡蛋白1 (PD-1) 抑制剂正在彻底改变经典的霍奇金淋巴瘤 (CHL) 治疗. 这些药物在新诊断的和复发/耐药性CHL患者中都显示出高疗效,在各种治疗环境中改善了结果.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

241
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K